This case history describes a case of rhabdomyolysis resulting from treatment with escitalopram as monotherapy at the recommended dose. This is a rare and little-known side effect of selective serotonin reuptake inhibitors.
Kamilla Kvikstad Mathisen, Randolf Hardersen. Escitalopram-associated rhabdomyolysis. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. 2023 Sep 05;143(12)
Mesh Tags
Substances
PMID: 37668131
View Full Text